Nicolau Ioana A, Warkentin Matthew T, Graff Kirk, Doll Corinne, Bryant Heather, Brenner Darren R
Department of Oncology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
JCO Oncol Adv. 2025 Jul 9;2(1):e2400101. doi: 10.1200/OA-24-00101. eCollection 2025.
The vast majority of cervical cancer is preventable through human papillomavirus vaccination and screening with cytology or DNA testing. After decades of progress, recent cervical cancer trends in Western populations show a plateau or modest increase in incidence rates. Further investigation is required to understand the drivers of these emerging trends. In this study, we examined age-specific cervical cancer incidence rates in Canada from 1992 to 2022.
Data were obtained from the Canadian Cancer Registry maintained by Statistics Canada, which included cancer cases, population counts, and incidence rates of cervical cancer by age and province for the period 1992 to 2022. Joinpoint regression analysis was used to estimate temporal incidence trends across age groups.
Cervical cancer incidence rates in Canada decreased among women age 25-34 years and those 65 years and older since 1992. Incidence rates among women age 35-44 years and 45-54 years have increased by 1.1% (95% CI, 0.5 to 2.5) and 1.6% (95% CI, -0.1 to 8.6) per year since 2001 and 2012, respectively. In 2022, the highest incidence rate of cervical cancer was among women age 35-44 years (18.1 per 100,000 women), which is comparable with rates in 1992.
Cervical cancer incidence rates have been increasing in recent years among women age 35-54 years. This cohort may be falling into a cancer prevention gap. Targeted public health interventions are warranted to address the rising incidence of cervical cancer among this cohort of Canadian women.
通过人乳头瘤病毒疫苗接种以及细胞学或DNA检测筛查,绝大多数宫颈癌是可预防的。经过数十年的进展,西方人群近期的宫颈癌发病趋势显示发病率趋于平稳或略有上升。需要进一步调查以了解这些新趋势的驱动因素。在本研究中,我们调查了1992年至2022年加拿大特定年龄组的宫颈癌发病率。
数据来自加拿大统计局维护的加拿大癌症登记处,其中包括1992年至2022年期间的癌症病例、人口计数以及按年龄和省份划分的宫颈癌发病率。采用Joinpoint回归分析来估计各年龄组的时间发病趋势。
自1992年以来,加拿大25至34岁以及65岁及以上女性的宫颈癌发病率有所下降。自2001年和2012年以来,35至44岁以及45至54岁女性的发病率分别以每年1.1%(95%置信区间,0.5至2.5)和1.6%(95%置信区间,-0.1至8.6)的速度上升。2022年,宫颈癌发病率最高的是35至44岁的女性(每10万名女性中有18.1例),这与1992年的发病率相当。
近年来,35至54岁女性的宫颈癌发病率一直在上升。这一年龄组可能正陷入癌症预防缺口。有必要采取有针对性 的公共卫生干预措施,以应对加拿大这一年龄组女性中不断上升的宫颈癌发病率。